Access Community Clinical Trials
↗Baton Rouge, Louisiana
Access Community Clinical Trials (ACCT) is a clinical trial management company and site network founded in 2024. The company specializes in integrating clinical research departments into existing community medical practices, with a core focus on improving health equity by ensuring diverse patient populations have access to cutting-edge therapies.
Beyond site management, ACCT provides 'Rescue & Consultation' services for underperforming clinical trial sites. They assist sites struggling with quality, financial viability, or recruitment by implementing robust quality management programs, staffing analyses, and advanced technology stacks for remote monitoring and data collection.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Site Network / Site Management Organization (SMO)
SIZE & FINANCIALS
Employees:1-50
Revenue:Under $1M
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Seed/Self-funded
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Community Medical Practices (Site Network Partners), Velocity Clinical Research (Historical/Strategic connection)
COMPETITION
Position:Emerging
Competitors:Velocity Clinical Research, Meridian Clinical Research, CenExel, Carebox, Elligo Health Research
LEADERSHIP
Key Executives:
Michelle Hurst - CEO & Co-founder
Kristi Rau - Co-founder
LINKS
Website:accesscct.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Access Community Clinical Trials. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.